US Patent Office to Confirm Kite’s Seminal Eshhar CAR-T Patent – Business Wire (press release)
|
US Patent Office to Confirm Kite's Seminal Eshhar CAR–T Patent
Business Wire (press release) SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that the United States Patent and Trademark Office (USPTO) has provided a Notice of Intent to issue an Ex Parte Reexamination … |
